NDST Inhibitors

N-Deacetylase/N-Sulfotransferase (NDST) inhibitors represent a class of compounds designed to target a crucial step in the biosynthesis of heparan sulfate (HS), a complex and highly sulfated glycosaminoglycan (GAG) that plays essential roles in various physiological and pathological processes. Heparan sulfate chains are composed of repeating disaccharide units, each comprising an N-acetylglucosamine (GlcNAc) and a glucuronic acid (GlcA) residue. The NDST enzymes, specifically NDST-1 and NDST-2, catalyze a critical modification step by removing the N-acetyl group from GlcNAc and replacing it with a sulfate group, thus forming N-sulfated glucosamine residues. This enzymatic action is pivotal for the generation of HS chains with high sulfation patterns, which are integral in mediating the interactions between HS and various proteins, including growth factors, cytokines, enzymes, and adhesion molecules.

NDST inhibitors are synthetically designed molecules that interfere with the NDST enzyme's activity, primarily by competitively binding to its active site or modulating its function in some way. By inhibiting NDST, these compounds disrupt the sulfation pattern of heparan sulfate chains, resulting in altered HS structures with reduced sulfation. This structural modification can significantly impact the HS-protein interactions, leading to downstream effects on cellular processes such as cell signaling, growth, adhesion, and viral entry. Researchers have utilized NDST inhibitors as valuable tools in elucidating the role of HS and its sulfation patterns in various biological contexts, including development, inflammation, and viral infection. These inhibitors have contributed to a deeper understanding of the complex and multifaceted functions of heparan sulfate in health and disease, providing insights into avenues for further research and drug development efforts, albeit without direct implications.